A clinical trial is a research study that tests the safety and efficacy of a new medical intervention, such as a drug, vaccine, or procedure, in human participants. It is a test based on statistics to draw an inference from a sample group.

WHAT IS A CLINICAL TRIAL?

THE PROBLEM WITH CLINICAL TRIALS?

Completing a clinical trial is a complicated and intricate process that usually spans years. Current clinical trials are inflexible and expensive, with no guarantee of either success or failure.

ENABLING ALL CLINICAL TRIALS TO BE ADAPTIVE WOULD HELP SOLVE THIS PROBLEM.

Adaptive trial design allows modifications to the trial and/or statistical procedures of the trial after its initiation without undermining its validity and integrity while optimizing its chances of success.

TRIALCLARITY IS THE NEW PARADIGM.

TrialClarity enables adaptive trials through AI/ML and distributed technologies through real time analysis with the use of Bayesian statistical inference.

In 2021, there were 365,000 registered clinical studies.

By May 2024, there were 515,000 registered clinical studies.

The opportunity is enormous.

TrialClarity was founded in 2021 to address the unmet need to enable all clinical trials to be adaptive. Through the application and integration of AI/ML technologies, TrialClarity’s mission is to empower researchers to overcome challenges and achieve groundbreaking results, all while preserving the purity of the data. Our team of experts are building on decades of experience in biopharma, drug development, and IT.